Qureight

AI-driven insights for faster drug approvals.

Edited:

📋 Overview of Qureight

Founding Year

2018

Estimated Funding

$0000

Size

$0000

Primary Industry

Data Analytics, Industry

📙 About Qureight

Qureight utilizes AI and data curation to expedite drug development, focusing on lung and heart diseases. By collaborating with pharmaceutical companies, contract research organizations, and hospitals, it optimizes clinical trial processes through intelligent data analysis and integration. Their technology uncovers critical insights from complex trial data, enhancing decision-making and accelerating the approval of life-saving drugs.

💰 Recent Investors of Qureight

Cambridge Angels, Guinness Ventures, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.